Completed PHASE3 INTERVENTIONAL 2-arm NCT00694694

Azithromycin + Artesunate v Artemether-lumefantrine in Uncomplicated Malaria. (CAZAMS)

A Randomized Trial of Azithromycin + Artesunate v Artemether-lumefantrine in Uncomplicated Malaria in Tanzanian Children.

Sponsor: London School of Hygiene and Tropical Medicine

Conditions Malaria

Interventions artemether-lumefantrine azithromycin + artesunate

Updated 5 times since 2017 Last updated: Oct 19, 2016 Started: Jun 30, 2008 Primary completion: Dec 31, 2008 Completion: Feb 28, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00694694, this PHASE3 trial focuses on Malaria and remains completed. Sponsored by London School of Hygiene and Tropical Medicine, it has been updated 5 times since 2008, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

London School of Hygiene and Tropical Medicine
National Institute for Medical Research, Tanzania

Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Muheza, Tanzania